BamSEC and AlphaSense Join Forces
Learn More

Nektar Therapeutics

NASDAQ: NKTR    
Share price (12/20/24): $0.93    
Market cap (12/20/24): $171 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant Nektar Therapeutics
12/34/56
EX-4.3
from S-3ASR 39 pages Nektar Therapeutics Issuer and [Trustee], Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56
EX-4.2
from S-3ASR 37 pages Nektar Therapeutics Issuer and [Trustee], Trustee Indenture Dated as of [ ] Senior Debt Securities
12/34/56
EX-4.4
from 10-K 4 pages Indenture or similar
12/34/56
EX-4.1
from 10-Q 50 pages Investor Agreement
12/34/56
EX-4.1
from 8-K 1 page /S/ Robert B. Chess February 24, 2006 Robert B. Chess Date
12/34/56
EX-4.1
from 8-K 1 page January 9, 2006 Sincerely, Offer Accepted: /S/ Ajit Gill Ajit Gill CEO and President /S/ Louis Drapeau 1/10/06 Louis Drapeau Date 1/17/06 Start Date
12/34/56
EX-4.2
from 8-K 31 pages Registration Rights Agreement Among Nektar Therapeutics, Merrill Lynch, Pierce, Fenner & Smith Incorporated Lehman Brothers Inc. Goldman, Sachs & Co. Deutsche Bank Securities Inc. W.R. Hambrecht + Co, LLC Leerink Swann & Company Sg Cowen & Co., LLC and Suntrust Capital Markets, Inc. Dated as of September 28, 2005
12/34/56
EX-4.1
from 8-K 108 pages Indenture Between Nektar Therapeutics, as Issuer and J.P. Morgan Trust Company, National Association as Trustee 3.25% Convertible Subordinated Notes Due 2012 Dated as of September 28, 2005
12/34/56
EX-4.12
from S-3 44 pages Nektar Therapeutics, Issuer and J.P. Morgan Trust Company, National Association, Trustee Indenture Dated as of [ • ] Subordinated Debt Securities
12/34/56
EX-4.11
from S-3 43 pages Nektar Therapeutics, Issuer and J.P. Morgan Trust Company, National Association, Trustee Indenture Dated as of [ • ] Senior Debt Securities
12/34/56
EX-4.3
from 8-K 22 pages Resale Registration Rights Agreement
12/34/56
EX-4.2
from 8-K 3 pages First Supplemental Indenture
12/34/56
EX-4.3
from 8-K 18 pages Form of Security [Face of Security]
12/34/56
EX-4.2
from 8-K 25 pages Resale Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 109 pages Indenture Between Nektar Therapeutics, as Issuer and J.P. Morgan Trust Company, National Association as Trustee 3% Convertible Subordinated Notes Due 2010 Dated as of October 9, 2003
12/34/56
EX-4.29
from S-3 ~50 pages Nektar Therapeutics, Issuer and J.P. Morgan Trust Company, National Association, Trustee Indenture Dated as of [ • ], 2003 Subordinated Debt Securities
12/34/56
EX-4.28
from S-3 ~50 pages Nektar Therapeutics, Issuer and J.P. Morgan Trust Company, National Association, Trustee Indenture Dated as of [ • ], 2003 Senior Debt Securities
12/34/56
EX-4.3
from 8-K 111 pages Indenture Between Nektar Therapeutics, as Issuer and J.P. Morgan Trust Company, National Association as Trustee 3% Convertible Subordinated Notes Due 2010 Dated as of June 30, 2003
12/34/56
EX-4.2
from 8-K 26 pages Resale Registration Rights Agreement Among Nektar Therapeutics, Merrill Lynch, Pierce, Fenner & Smith Incorporated Deutsche Bank Securities Inc. Lehman Brothers Inc. Friedman, Billings, Ramsey & Co., Inc. and Sg Cowen Securities Corporation Dated as of June 30, 2003
12/34/56